Michael Farr, DO
Orthopaedic Surgery · Havre, MTNPI 1063618833
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (46.0%), education and food and beverage — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Arthrex at 34.6% of the total. Reporting peaked in 2022 at $2,926 and has fallen 99.3% since, to $21 in 2024.
Across 34 payments — averaging $131.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$2K
- Rattan And Associates$1K
- Zimmer Biomet$1K
- Johnson & Johnson$75
- Pacira Therapeutics, Inc.$71
- Stryker$59
- plus $123 from 4 others
What the payments were for
- Travel & lodging$2,05846%
- Food & beverage$78117%
- Education$1,63136%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 3 | $1,548 |
| Rattan And Associates | 4 | $1,324 |
| Zimmer Biomet | 12 | $1,272 |
| Johnson & Johnson | 4 | $75 |
| Pacira Therapeutics, Inc. | 5 | $71 |
| Stryker | 2 | $59 |
| Davol Inc. | 1 | $46 |
| Dynasplint Systems Inc. | 1 | $36 |
| Bioventus LLC | 1 | $23 |
| Baudax Bio Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Juggerknot$348
- Persona$337
- AperFix Femoral Fixation$123
- Comprehensive Reverse$112
How this compares
$4,470 in reported general payments places this provider in the 65th percentile of 76 orthopaedic surgery providers in Montana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 70 | $222 |
| Gabapentin | 17 | $129 |
| Tramadol Hcl | 19 | $44 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Havre
- Michelle Cameron-DonaldsonHavre$1K
- Brian DrakeBillings$84K
- Daniel WhitingMissoula$39K
- Daniel DixonMissoula$38K
- Matthew KopplinBillings$35K
- Chase DukesHelena$34K
- Jace BullardGreat Falls$29K
- John WernerMissoula$24K
- Matthew AndersonPolson$23K
- Zackery WitteMissoula$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.